We represented ClearPoint Neuro, Inc. (f/k/a MRI Interventions, Inc.), a global therapy-enabling platform company providing navigation and delivery to the brain, in its $17.5 million strategic investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management, with $10.0 million of notes funded by PTC and $7.5 million of notes funded by Petrichor. With the net proceeds from the sale of the notes to PTC and Petrichor, the ClearPoint Neuro intends to repay in full its existing secured indebtedness, and to fund product commercialization, internal research and development, and general corporate requirements. Additionally, we advised ClearPoint Neuro in the draw of $7.5 million additional proceeds from Petrichor in December 2020. ClearPoint Neuro intends to use net proceeds to continue funding global product commercialization, external strategic portfolio partnerships, and internal research and development efforts.
ClearPoint Neuro, Inc. (f/k/a/ MRI Interventions, Inc.) Closes $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management and Announces Additional $7.5 Million Strategic Investment in December 2020.
You Also May Be Interested In:
Served as fund formation counsel for the formation, capitalization, closing and operation of Brown Robin Partners’ current fund.
Representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be acquired by funds managed by Stone Point Capital, with over $40 billion of assets under management; under the terms of the agreement, Tivity Health stockholders will receive $32.50 in cash per share, representing a total transaction value of $2.0 billion
Representation of Groups360, a leading platform for booking group travel, in its $35,000,000 investment from Zigg Capital, Blackstone Innovations Investments, and Fir Tree Partners to accelerate growth.